欢迎来到 PANAGENE中国区代理商/公司/官网
全国咨询热线： 18771997407
产品中心 细胞生物学产品 分子生化产品 免疫学产品 植物学产品
联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话：18372041646

传真：18771149750

邮箱：sales@amyjet.com

新闻中心
Berry & Associates.png

艾美捷科技代理Berry & Associates全系列修饰核苷酸等


美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

 

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry.  High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.


Berry & Associates的主要产品包括：

产品名称产品编号纯度规格
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2'-3'-DideoxyguanosinePR 3505≥95%25 mg; 100 mg
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
2',3'-DideoxyuridinePY 7278≥97%100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridinePY 7279≥97%25 mg; 100 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
2-Amino-2'-deoxyadenosinePR 3060≥97%1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosinePR 3080≥95%100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosinePR 3130≥95%100 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purinePR 3670≥95%100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purinePR 3070≥97%25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purinePR 3160≥97%100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine HemihydratePR 3180≥97%25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purinePR 3680≥97%100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosinePR 3006≥95%25 mg; 100 mg
8-Amino-2'-deoxyadenosinePR 3115≥97%10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosinePR 3120≥90%100 mg; 1 g
8-Azido-2'-deoxyadenosinePR 3125≥97%10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosinePR 3230≥95%50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosinePR 3260≥95%100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosinePR 3280≥97%100 mg; 1 g
8-Bromo-2'-deoxyadenosinePR 3290≥90%2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3320≥95%100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3340≥97%0g (discontinued);  
2'-Deoxyadenosine MonohydratePR 3445≥97%25 g; 100 g
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2-Fluoro-2'-deoxyadenosinePR 3496≥97%25 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
N6-Methyl-2'-deoxyadenosinePR 3740≥97%100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridinePRA 10012≥95%10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosinePRA 10032≥95%10 mg; 50 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosinePR 3010≥90%0Discontinued;  
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3015≥90%1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3020≥90%1 g; 10 g
5'-Azido-5'-deoxyguanosinePR 3225≥90%5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3285≥90%1 g; 10 g
8-Bromo-2'-deoxyguanosinePR 3300≥90%1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosinePR 3310≥97%500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3330≥90%250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosinePR 3335≥95%100 mg; 1 g
2'-Deoxyguanosine monohydratePR 3452≥97%10 g; 100 g
α-2'-DeoxyguanosinePR 3455≥97%10 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosinePR 3600≥97%100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosinePR 3605≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosinePR 3630≥97%100 mg; 1 g
N2-Ethyl-2'-deoxyguanosinePR 3700≥95%25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosinePR 3745≥97%10 mg; 100 mg
N1-Methyl-2'-deoxyguanosinePR 3748≥97%25 mg; 1 g
N2-Methyl-2'-deoxyguanosinePR 3750≥97%25 mg; 100 mg
O6-Methyl-2'-deoxyguanosinePR 3755≥90%5 mg; 25 mg
6-Thio-2'-deoxyguanosinePR 3845≥97%10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
2'-O-MethyladenosinePR 3734≥97%1 g;  
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridinePY 7575≥97%10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridinePY 7577≥97%10 mg; 100 mg
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosinePR 3000≥97%25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosinePR 3200≥90%50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosinePR 3210≥97%10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosinePR 3220≥97%10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosinePR 3240≥97%100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosinePR 3250≥97%100 mg; 1 g
3'-DeoxyadenosinePR 3430≥97%10 mg; 100 mg
3'-DeoxyguanosinePR 3460≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosinePR 3590≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosinePR 3690≥97%20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridinePY 7230≥97%100 mg;  
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3040≥97%1 g;  
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3045≥95%1 g;  
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purinePR 3050≥95%5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3370≥97%100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3380≥90%100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purinePR 3390≥97%0 g;  
6-Chloro-9-(β-D-ribofuranosyl)purinePR 3400≥97%5 g; 10 g
AdenosinePR 3005≥97%100 g; 1 kg
8-MethyladenosinePR 3007≥95%25 mg; 100 mg
VidarabinePR 3008≥97%1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
N1-Methyladenosine hydroiodidePR 3032≥95%100 mg; 1 g
2-MethyladenosinePR 3035≥97%10 mg; 25 mg
5'-Chloro-5'-deoxyadenosinePR 3360≥97%100 mg; 1 g
N6-MethyladenosinePR 3732≥97%100 mg; 1 g
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10000≥97%100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10005≥97%500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridinePRA 10006≥90%25 mg; 100 mg
8-AzaadenosinePRA 10007≥97%20 mg;  
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)PRA 10008≥95%10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidinePRA 10009≥95%100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosinePRA 10010≥97%100 mg; 1 g
Allopurinol ribosidePRA 10011≥97%25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosinePRA 10020≥97%100 mg; 1 g
3-Deaza-2'-deoxyadenosinePRA 10025≥97%25 mg; 100 mg
7-Deaza-2'-deoxyadenosinePRA 10030≥97%100 mg; 1 g
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
7-Deaza-2'-deoxyguanosinePRA 10040≥97%100 mg; 1 g
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
7-Deaza-2'-deoxyxanthosinePRA 10050≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosinePRA 10055≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
5-IodotubercidinPRA 10095≥90%5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10100≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10110≥97%100 mg; 1 g
SangivamycinPRA 10140≥97%10 mg; 25 mg
ToyocamycinPRA 10150≥97%10 mg; 100 mg
TriciribinePRA 10160≥97%10 mg;  
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg;  
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
dNaMFC 8110≥97%25 mg; 100 mg
9-Deaza-2'-deoxyguanosinePRA 10120≥97%10 mg; 100 mg
9-DeazaguanosinePRA 10130≥97%10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazinePYA 11000≥97%10 mg; 25 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
PyrazofurinPYA 11004≥97%10 mg;  
2'-DeoxypseudoisocytidinePYA 11005≥97%10 mg; 100 mg
2'-DeoxypseudouridinePYA 11010Purity: ≥97%25 mg; 
5'-O-(Dimethoxytrityl)-N-(dimethylamino)
methylidene-2'-deoxypseudoisocytidine		PYA 11035Purity: ≥97%50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridinePYA 11040≥97%10 mg; 100 mg
1,3-DimethylpseudouridinePYA 11050≥97%10 mg; 50 mg
N1-MethylpseudouridinePYA 11052≥95%10 mg; 50 mg
N3-MethylpseudouridinePYA 11054≥97%10 mg; 25 mg
ShowdomycinPYA 11056≥97%10 mg;  
Pseudoisocytidine hydrochloridePYA 11060≥97%10 mg; 100 mg
PseudothymidinePYA 11070≥97%10 mg; 100 mg
PseudouridinePYA 11080≥97%10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosinePR 3350≥97%10 mg;  
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-Deoxy-8,5'-cycloadenosinePR 3440≥97%10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosinePR 3500≥97%10 mg;  
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosinePR 3730≥97%10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosinePR 3800≥97%10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosinePR 3810≥97%10 mg;  
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidinePY 7054≥97%25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
5-Bromo-2'-deoxycytidinePY 7115≥97%1 g; 10 g
CytidinePY 7215≥97%50 g; 500 g
2'-DeoxycytidinePY 7216≥97%10 g; 50 g
2'-Deoxycytidine HydrochloridePY 7217≥97%5 g; 50 g
5'-Azido-2',5'-dideoxycytidinePY 7219≥97%25 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
N4-Ethyl-2'-deoxycytidinePY 7245≥97%100 mg; 250 mg
5-Methyl-2'-deoxyisocytidinePY 7255≥95%500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7270≥97%20 mg; 50 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7380≥97%50 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidinePY 7410≥97%100 mg;  
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-onePY 7540≥95%250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydratePY 7586≥95%50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidinePY 7587≥97%10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidinePY 7588≥97%50 mg; 100 mg
5-Formyl-2'-deoxycytidinePY 7589≥97%5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidinePY 7592≥95%25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium saltPY 7593≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-HydroxymethylcytidinePY 7596≥97%50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium saltPY 7598≥97%10 mg; 50 mg
5-FormylcytidinePY 7599≥97%5 mg; 10 mg
5-Iodo-2'-deoxycytidinePY 7607≥97%2 g; 10 g
5-IodocytidinePY 7609≥97%5 g;  
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Methyl-2'-deoxycytidine HydrochloridePY 7635≥97%0.25 g; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-MethylcytidinePY 7637≥97%1 g; 5 g
N4-MethylcytidinePY 7638≥97%25 mg; 100 mg
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
2-ThiocytidinePY 7721≥97%10 mg; 100 mg
2-Thio-2'-deoxycytidinePY 7723≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
8-HydroxyguanosinePR 3795≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
5-Aza-2'-deoxycytidinePY 7105≥95%25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidinePY 7106≥97%25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
Nap-dUPY 7735≥97%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
8-18O-HydroxyguanosineIOPR 3795≥95%2 mg; 5 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
N2-DimethylguanosinePR 3702≥97%10 mg; 100 mg
GuanosinePR 3703≥97%100 g; 500 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
O6-MethylguanosinePR 3757≥97%25 mg; 100 mg
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
8-BromoguanosinePR 3796≥97%0 g;  
8-BenzyloxyguanosinePR 3797≥95%100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
2'-Deoxy-4-desmethylwyosinePR 3450≥95%100 mg; 500 mg
2'-DeoxyinosinePR 3463≥97%10 g; 100 g
5'-Azido-2',5'-dideoxyinosinePR 3464≥97%5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosinePR 3480≥97%1 g;  
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosinePR 3490≥90%1 g;  
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosinePR 3660≥97%100 mg; 1 g
InosinePR 3725≥97%100 g; 500 g
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
O6-Phenyl-2'-deoxyinosinePR 3840≥97%100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3842≥97%25 mg;  
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3843≥90%25 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosinePR 3510≥90%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3520≥95%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3530≥90%100 mg; 1 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
d5SICSFC 8120≥97%25 mg; 100 mg
AICA Riboside (AICAR)MN 20001≥97%0 g (DISCONTINUED);  
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosinePR 3692≥95%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
tC NucleosidePYA 11110≥97%50 mg; 100 mg
tCnitro NucleosidePYA 11115≥95%5 mg; 25 mg
2'-DeoxynebularinePR 3470

Purity: ≥97%		100 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrolePYA 11020≥97%50 mg;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrolePYA 11030≥95%100 mg;  
ShowdomycinPYA 11056≥97%10 mg; 
Formycin APYA 11001≥97%10 mg; 
Formycin BPYA 11002≥97%10 mg; 
PseudouridinePYA 11080≥97%10 mg; 
PyrazofurinPYA 11004≥97%10 mg; 
ToyocamycinPRA 10150≥97%10 mg; 
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 
Allopurinol ribosidePRA 10011≥97%25 mg; 
5-IodotubercidinPRA 10095≥90%5 mg; 
TriciribinePRA 10160≥97%10 mg; 
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg; 
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 
5'-Amino-5'-deoxythymidinePY 7030≥97%25 mg; 50 mg
O2,5'-AnhydrothymidinePY 7060≥95%500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
5'-Azido-5'-deoxythymidinePY 7070≥97%25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7120≥97%1 g;  
3'-O-(t-Butyldimethylsilyl)thymidinePY 7130≥95%500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidinePY 7140≥97%5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidinePY 7150≥97%1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidinePY 7160≥95%100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidinePY 7200≥95%10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidinePY 7210≥95%10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7250≥97%1 g;  
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-onePY 7315≥90%1 g; 10 g
2',3'-Didehydro-3'-deoxythymidinePY 7328≥95%10 mg; 100 mg
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidinePY 7510≥97%50 mg; 100 mg
2-O-EthylthymidinePY 7561≥97%500 mg; 1 g
5'-Iodo-5'-deoxythymidinePY 7610≥97%250 mg; 1 g
5'-O-MethylthymidinePY 7680≥95%50 mg; 100 mg
2-ThiothymidinePY 7725≥95%20 mg; 100 mg
ThymidinePY 7727≥97%25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidinePY 7740≥97%5 g;  
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidinePY 7750≥97%50 mg;  
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
6-AzathymidinePYA 11058≥95%25 mg; 100 mg
NPOM-Caged-dT CEPBA 0317≥95%100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
5-Ethynyl uridine CEPBA 0353≥90%100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridinePY 7053≥97%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-onePY 7055≥97%20 mg; 100 mg
5-Bromo-2'-deoxyuridinePY 7117≥97%10 g; 25 g
5-BromouridinePY 7118≥95%5 g;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carbomethoxyvinyl)uridinePY 7172≥97%25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridinePY 7185≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridinePY 7212≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
2'-DeoxyuridinePY 7275≥97%25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridinePY 7280≥95%100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7310≥97%20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridinePY 7450≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridinePY 7465≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-Ethynyl-2'-deoxyuridinePY 7562≥97%25 mg; 100 mg
5-Ethynyl uridinePY 7563≥97%10 mg; 100 mg
5-Fluoro-2'-deoxyuridinePY 7565≥97%100 mg; 1 g
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7580≥97%25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7590≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridinePY 7604≥97%25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridinePY 7612≥95%100 mg;  
5-Iodo-2'-deoxyuridinePY 7615≥97%10 g; 25 g
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
5-IodouridinePY 7632≥95%5 g; 25 g
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
3-MethyluridinePY 7694≥97%25 mg; 100 mg
5-MethyluridinePY 7695≥97%200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridinePY 7712≥95%10 mg; 100 mg
ZebularinePY 7715≥97%10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridinePY 7720≥90%500 mg; 1 g
2-ThiouridinePY 7724≥97%25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridinePY 7730≥97%1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridinePY 7758≥97%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridinePY 7775≥97%100 mg; 1 g
UridinePY 7780≥97%100 g; 500 g
2'3'-O-Isopropylidene uridinePY 7781≥97%5 g; 25 g
5-Hydroxymethyl uridinePY 7782≥97%50 mg; 100 mg
5-MethoxyuridinePY 7783≥97%10 mg; 50 mg
6-Aza-2'-deoxyuridinePYA 11057≥95%50 mg; 100 mg

" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
...
阅读详情
exocell.jpgjgfinneran.jpg

艾美捷科技代理JGFInneran品牌。

JGFInneran在生物技术和实验室设备领域具有显著优势，凭借高质量产品和定制化服务，赢得了广泛的市场认可。JGFInneran提供先进的控制系统，实现精确的温度、pH、溶氧控制；采用高质量材料，使用不锈钢和玻璃等耐腐蚀材料，确保设备耐用；自动化与数据记录: 支持自动化操作和实时数据记录，便于实验监控和分析。应用领域包括：生物制药: 用于单克隆抗体、疫苗等生产；生物燃料: 用于微生物发酵生产乙醇等；食品与饮料: 用于发酵工艺优化；学术研究: 为科研机构提供实验设备。

JGFInneran公司主要产品包括：

（1）生物反应器：用于细胞培养和发酵，广泛应用于生物制药、疫苗生产和生物燃料开发。

（2）发酵罐：适用于微生物和细胞培养，具备高精度控制和自动化功能。

（3）实验室设备：提供搅拌器、泵、传感器等，满足实验室的多样化需求。

（4）定制解决方案：根据客户需求，提供定制化的生物反应器和发酵罐。




<<< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理JGFInneran品牌"> 艾美捷科技代理JGFInneran品牌
...
阅读详情
Diacron 2.5比1.png

<

艾美捷科技代理Diacron品牌全系列产品

Diacron是一个在人类、兽医和农业食品领域拥有30多年研究和诊断经验的企业。由Mauro Carratelli创建，以CARR测量单位闻名，专注于测量导致老化的氧化过程。开发了创新的测量方法，用于评估氧化应激和农业食品参数，其测试和仪器被广泛应用于氧化剂和抗氧化剂的监测，服务于研究和医学以及农业食品领域的专业人员，在1800多项科学研究中被使用，并以提供科学和技术援助而著称。作为意大利和全球知名的研究中心、实验室和医学专家的官方供应商，还通过了ISO 13485: 2016和ISO 9001: 2015认证，确保高质量的医疗器械生产和产品设计。其产品主要面向农业食品和人类兽医领域。

● 农业食品部门：生产用于化学分析的仪器和试剂，特别适用于葡萄酒、葡萄汁、油、醋和干果生产链中参数的光度法分析。目标客户包括小型和大型生产商、酿酒师和专业人士，为生产过程提供支持。

● 人类和兽医部门：参与生产用于自由基和抗氧化剂生化分析的试剂和仪器，面向在人类和兽医领域的研究和临床环境中工作的专业人士。


Diacron页面.png


▍Diacron产品列表


品名分类类型Scope
d-ROMs TestBloodPro oxidantHuman and Veterinary
IndicanoUrinePro oxidantHuman
BAP TestBloodantioxidantHuman and Veterinary
OXY-Adsorbent TestBloodantioxidant-
anti-ox Sperm TestSperm fluidantioxidant-
URIN-OX TestUrinePro oxidantHuman and Veterinary
ROSA TestSalivaPro oxidantHuman
LP Sperm TestSperm fluidPro oxidantHuman and Veterinary
LipocellCells and TissuesPro oxidantHuman and Veterinary
LipotissCells and TissuesPro oxidantHuman and Veterinary
OXY-Reducing TestBloodantioxidantHuman and Veterinary
anti-ROMs TestBloodantioxidantHuman, Veterinary and Agrifood.
LP Cholox TestBloodPro oxidant-
MAc TestBloodPro oxidant-
SHp TestBloodantioxidantHuman and Veterinary


" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Diacron品牌全系列产品"> 艾美捷科技代理Diacron品牌全系列产品
...
阅读详情
exocell.jpgOcean Nanotech LOGO 2.5比1.jpg

艾美捷科技代理Ocean Nanotech品牌纳米材料。

Ocean Nanotech, LLC专注于纳米材料、纳米技术及其生物医学应用。Ocean Nanotech公司技术特点在于：采用先进的合成技术，确保纳米材料的高纯度和高稳定性；多功能应用: 纳米材料具有广泛的应用前景，包括生物医学、光学、电子学等领域；定制化服务: 提供灵活的定制纳米材料设计和生产服务，满足客户需求。Ocean Nanotech公司纳米材料应用广泛，包括生物标记、细胞成像、药物传递和癌症治疗；光学传感器、光催化和光学成像；用于电子器件、传感器和导电材料；用于环境监测和污染治理。


Ocean Nanotech公司产品包括：

（1）纳米颗粒：提供多种纳米颗粒，包括金纳米颗粒、银纳米颗粒、量子点等，用于生物医学、光学和电子学应用。

（2）纳米材料试剂盒：提供用于生物标记、细胞成像和药物传递的纳米材料试剂盒。

（3）定制纳米材料：根据客户需求，提供定制化的纳米材料设计和生产服务。

（4）纳米技术咨询服务：提供纳米技术相关的咨询和技术支持服务。


<<< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ocean Nanotech品牌纳米材料"> 艾美捷科技代理Ocean Nanotech品牌纳米材料
...
阅读详情
Foxx Life Sciences.png

Foxx Life Sciences公司位于美国新罕布什尔州Salem，是一家专门从事实验室耗材研发、生产、销售的公司，旗下产品主要包括1）一次性耗材；2）过滤用品；3）液体管理用品；4）实验室生物安全用品；5）玻璃器皿等。

 

Foxx Life Sciences provides engineering services, OEM and Foxx labeled proprietary products to leading research and distribution companies for a wide variety of applications. Through strategic planning and acquisition, commitment, and hard work, Foxx has developed an unparalleled reputation for technical expertise, quality and value. Our focus on next generation patented filtration, fluid management, and solvent waste products has accelerated our customers’ critical product-to-market timing objectives – a vital advantage in today’s competitive market.

 

产品主要包括：

（1）SINGLE-USE BIOPROCESS

Custom Assembly

EZBio® Anchors

EZBio® Bottles

EZBio® Bottle Assy.

EZBio® Cap Assy.

EZBio® Custom Bags

EZBio® Vent Filters

EZTop® Fluid Transfer

Filling & Venting

Sanitary Clamps

Silicone Tubing

True Union Clamps

（2）FILTRATION

Autofil® Bottle-Top

Autofil® Centrifuge

Autofil® Hardware

EZFlow® Cell Strainers

EZFlow® Glass Filtration

EZFlow® Membrane Discs

EZFlow® Syringe Filters

Vent Filters

（3）FLUID MANAGEMENT

Caps & Adapters

Carboys

Centrifuge Bottles

Erlenmeyer Flasks

HD Vacuum Bottles

Mixing

SECUREgrasp® Media Bottles

Storage Bottles

Secondary Containers

Teras Turbine Mixer

Tight-Head Containers

Vactrap™

VersaBarb & Spigots

Brewtainers

（4）LABORATORY SAFETY

HPLC Solvent Waste

Safety Cans

Safety Funnels

Accessories

Tubing Adapters

Vactrap™

（5）BOROSIL GLASSWARE

PUREGRIP® Bottles

PUREGRIP® Carboys

PUREGRIP® Flasks

Beakers

Bottles

Burettes

Condensers

Culture Tubes

Cylinders

Dessicators

Filtration Assembly

Funnels

Glass Flasks

Glass Stirrers

Pipettes

Test Tubes

Volumetric Flask

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Foxx Life Sciences"> Foxx Life Sciences
...
阅读详情
logo.png

<

艾美捷科技代理Bold Biotechnology（BBT）品牌全系列产品

Bold Biotechnology Co., Ltd (简称BBT)是一家综合性健康产业集团，拥有卓越的生命健康技术。BBT致力于研发全球最前沿的领先技术，涵盖以下领域：癌症预防、免疫细胞治疗（BAK、NK、DC免疫疗法）、外泌体研发、血清无免疫细胞用干细胞培养基、超早期癌症筛查、发酵马乳外泌体研发与生产，高浓度维他命C制备等十余项核心生物技术。BBT公司的主要包括细胞培养基相关产品以及免疫化学检测类相关产品。


BBT页面.png


▍BBT公司产品线

● αβ-T・γδ-T细胞培养基及配套产品

EALI515-T 无血清培养基：专用于人类及小鼠外周血淋巴细胞的培养。该培养基支持多种淋巴细胞的增殖与活化（包括αβ-T细胞、γδ-T细胞、CTL细胞、NKT细胞及NK细胞），适用于癌症免疫疗法。


ProductDescriptionCodePackageStore at
EALITM515-T (Without IL-2)Originally modified medium based on Iscove’s modified Dulbecco’s Medium (IMDM).
Basal medium for low-serum or serum-free culture of human and mouse Lymphoblast cells.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture teste		15021,000 mL2～10℃


● NK细胞培养基

EALI515-NK 无血清培养基：专用于人类自然杀伤细胞（NK细胞）培养。本培养基支持NK细胞的活化与增殖，适用于癌症免疫疗法。

<
ProductDescriptionCodePackageStore at
EALITM515-NK (Without IL-2)Basal medium for low-serum or serum-free culture of human and mouse Lymphoblast & NK cells.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested.		16021,000 mL2～10℃
EALITM515-NK (IL-2 700 IU/mL)Recommend for expansion culture of NK cells.
Containing 700 IU/mL of IL-2.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested.		16221,000 mL2～10℃
EALITM515-NK (IL-2 1,000 IU/mL)Recommend for early stage culture of NK cells.
Containing 1,000 IU/mL of IL-2.
pH: 7.1-7.6
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested		16321,000 mL2～10℃


● 间充质干细胞（MSCs）无血清/无异源培养基及配套产品

αMSCM 培养基：基于改良型αMEM基础培养基优化开发，支持牙髓、脐带、骨髓及脂肪组织来源间充质干细胞（MSCs）的无异源/低血清培养。

<
ProductDescriptionCodePackageStore at
Basal medium (modified αMEM) αMSCM BasalA basal medium without L-Glutamine and Cell Growth Factors (GFs). (containing rh-Transferrin and rh-Insulin).
This product can be used for low serum culture of various MSCs. Add 2mM L-Glutamine, Cell growth Factors and 2% Fetus Bovine Serum (FBS) before use.
Recommend use of x100 3GF Supplement (code: 3151F) as additive.		1801500 mL2～10℃
Xeno-Free culture medium αMSCM+PLThis Product is a set of Xeno-Free medium and human Platelet Lysate (hPL:UltraGro*). No need additional growth supplements, serum and cell adhesion molecule.1811500 mL2～10℃
Cell Growth factor mixture x100 3GF SupplementA mixture of recombinant human FGF-2, PDGF-BB and TGF-β1. Contains recombinant human albumin as a stabilizer.This product is lyophilized.3151F5 mg4~8°C


● 蛋白质生产用化学成分确定培养基

EALI515-MAb 培养基：杂交瘤细胞培养与抗体生产专用培养基，本产品采用无动物源性蛋白配方（不含血清白蛋白），能支持多种杂交瘤细胞的高效增殖并维持抗体生产能力。培养基中仅含胰岛素与转铁蛋白两种蛋白组分，相比含血清或白蛋白的培养基，可显著简化培养上清中单克隆抗体的分离纯化流程。

<
ProductDescriptionCodePackageStore at
EALI 515-MAbNewly designed chemically defined medium of Hybridoma cell culture and production of Monoclonal Antibody. Containing hr-Insulin and hr-Transferrin.
Without Serum Albumin or other animal derived proteins.
pH: 7.3-7.7
Osmolarity: 280-300 mOsm/Kg H2O
Membrane filtered, Endotoxin tested, Cell culture tested.		14021,000 mL2～10℃


● 其他细胞培养相关产品


ProductDescriptionCodePackageStore at
Dulbecco’s Phosphate Buffered Saline, “PBS(-)”Dulbecco’s Phosphate–Buffered Saline
pH: 7.3-7.5
Osmolarity: 276-284 mOsm/Kg H2O
Membrane filtered
Endotoxin tested		2101500 mLRoom temp.
Anti CD3 MAb for CIK TactimabTMAffinity purified anti-CD3 monoclonal antibody without preservative.
Manufactured by animal protein free culture of mouse Hybridoma clone OKT3 cell.
Stimulate the growth of human T Lymphocyte in vitro.

Membrane filtered.
Endotoxin tested.
T cell culture tested.
This product is lyophilized.		3121F1 ㎎Freezing
Anti CD3 MAb for CIK TactimabTMAffinity purified anti-CD3 monoclonal antibody without preservative.
Manufactured by animal protein free culture of mouse Hybridoma clone OKT3 cell.
Stimulate the growth of human T Lymphocyte in vitro.

Membrane filtered.
Endotoxin tested.
T cell culture tested.
This product is lyophilized.		3122F10 ㎎Freezing


● 免疫化学检测试剂盒与试剂


ProductDescriptionCodePackage
CTX-ELISA 1BPlate Wash Buffer x20 conc, W-181111 x 50 mL
CTX-ELISA 1BSTD/Sample Diluent, D-181121 x 50 mL
CTX-ELISA 1BAnti-CTX1B-ALP Diluent, D-281131 x 50 mL
CTX-ELISA 1BALP Substrate Solution (pNPP), R-181141 x 50 mL
CTX-ELISA 1BELISA Assay Plate CTX1B　81152 x 96 well
CTX-ELISA 1BAnti-CTX1B-ALP：Freeze dry powder81161 tube
CTX-ELISA 1BCTX-1B STD 5 ng/mL81171 x 100 μL
CTX-ELISA 1BAdhesive plastic sheet--6 sheet
CTX-ELISA 1BOperation manual--1
Plate Wash Buffer x20 conc. W-1x20 concentrated Tris-buffer(pH 7.5) with tween 20, blocking reagent and preservative.
20 hold dilute with pure water before use.		811150 mL
STD/Sample Diluent D-1Specially developed buffer solution to dissolve hydrophobic Ciguatoxin molecule into the water.
pH 7.5.Ready to use.		811250 mL
Anti-CTX1B-ALP Diluent D-2Specially designed buffer solution(pH 7.5) for dilution of alkaline-phosphatase conjugated antibody, with Mg++, blocking material and detergent. Ready to use.811350 mL
ALP Substrate Solution (pNPP) R-1Alkaline-phosphatase substrate solution.
Alkaline solution of 0.01% disodium p-Nitrophenylphosphate (pNPP).
pH10,Useful for colorimetric assay of Alkaline-phosphatase. Ready to use.		811450 mL
ELISA Assay Plate CTX1BAnti-CTX1B antibody immobilized 96 well micro-plate.
Protected with blocking reagents to stabilize antibodies.
More than 8 months store is possible under dry conditions of 4 ℃ or less.		81151 plate



" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Bold Biotechnology（BBT）品牌全系列产品"> 艾美捷科技代理Bold Biotechnology（BBT）品牌全系列产品
...
阅读详情
Separopore 2.5比1.png

<

艾美捷科技代理Separopore品牌全系列产品

Separopore是美国生物技术公司bioWORLD旗下的核心色谱品牌，Separopore专攻多孔琼脂糖微球色谱介质，主打 "高分辨率分离纯化" 技术，覆盖亲和色谱、离子交换、分子筛等应用场景。产品广泛应用于单克隆抗体/重组蛋白纯化、病毒载体（AAV, 慢病毒）捕获，疫苗抗原精制以及核酸/酶工程等领域。


Separopore页面.png


▍Separopore产品线


类型应用场景代表产品
亲和色谱介质抗体/融合蛋白纯化Separopore® Protein A/G
金属螯合介质组氨酸标签蛋白捕获Separopore® Ni-NTA
离子交换介质核酸/酶纯化Q/S SP/CM 系列
疏水层析介质膜蛋白/病毒纯化Phenyl/Octyl 系列
分子筛介质脱盐/缓冲液置换Separopore® SEC Beads


Separopore的材料特征：

①基质成分：交联 4% 或 6% 琼脂糖（agarose），形成刚性多孔珠状结构

②物理优势：高孔隙率 & 均一粒径（45-165 μm 可选）；耐压性强（可承受 >0.3 MPa 操作压力）；低非特异性吸附

③表面修饰：可定制化偶联 Protein A/G、镍离子、抗体、凝集素 等配体

▍Separopore部分产品列表


品名规格货号
AMP Separopore® 4B-CL1 g；3 g20181079
Anti-DYKDDDDK (FLAG) Red Separopore® 4B Microbeads viewIP™1 mL20181114
Goat Anti-Human IgG Separopore® 4B-CL5 mL20181134
L-Lysine Separopore® 4B-CL5 mL；10 mL；25 mL20181070
L-Methionine Separopore® 6B-CL10 mL；25 mL20181160
L-Phenylalanine Separopore® 4B-CL5 mL；10 mL；25 mL20181071
L-Proline Separopore® 6B-CL10 mL；25 mL20181161
L-Serine Separopore® 6B-CL10 mL；25 mL20181162
L-Threonine Separopore® 6B-CL10 mL；25 mL20181163
L-Valine Separopore® 6B-CL10 mL；25 mL20181164
Lens culinaris Lectin (LCA/LCH) - Separopore® 4B OnePASS™ Column3.25 mL；8 mL30330004-1
Lycopersicon esculentum Lectin (LEL/LEA) - Separopore® 4B OnePASS™ Column3.25 mL；6 mL30330005-1
Maackia amurensis Lectin (MAA/MAL I) - Separopore® 4B OnePASS™ Column3 mL20120088-1
Maclura pomifera Lectin (MPL/MPA) - Separopore® 4B OnePASS™ Column3 mL21511124-1
MagneZoom™ (Paramagnetic Beads) Control1 mL；2 mL20162011-2
Maltose Separopore® 4B (Epoxy-Coupled)10 mL；25 mL；50 mL；100 mL20181175
Mannose Separopore® 4B-CL (Divinyl Sulfone-Coupled)10 mL；25 mL；50 mL；100 mL20181019
Mannose Separopore® 4B-CL (Epoxy-Coupled)10 mL；25 mL；50 mL；100 mL20111005
Melibiose Separopore® 4B (Divinyl Sulfone-Coupled)10 mL；25 mL20181178
Melibiose Separopore® 4B (Epoxy-Coupled)10 mL；25 mL20181148-1
N-Acetyl-D-Galactosamine Separopore® 4B-CL2 mL；5 mL；10 mL20181021
N-Acetyl-D-Glucosamine (GlcNAc) Separopore® 4B-CL2 mL；5 mL；10 mL20181022
NAADP Separopore® 4B-CL2 g20181122
NAADP Separopore® 4B-CL (Carboxyl-Linked)2 g20181123
Nickel Red Separopore® 4B Microbeads viewIP™1 mL20181117
Phaseolus vulgaris Lectin (PHA-E) - Separopore® 4B OnePASS™ Column3.25 mL；6 mL30330023-1
Phaseolus vulgaris Lectin (PHA-E+L) - Separopore® 4B OnePASS™ Column3.25 mL；6 mL30330027-1
Phaseolus vulgaris Lectin (PHA-L) - Separopore® 4B OnePASS™ Column3.25 mL；6 mL30330036-1
Pisum sativum Lectin (PSA/PSL) - Separopore® 4B OnePASS™ Column3 mL21511137-1
" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Separopore品牌全系列产品"> 艾美捷科技代理Separopore品牌全系列产品
...
阅读详情
Affinity Immuno.jpg

艾美捷科技代理Affinity Immuno品牌。

Affinity Immuno（AffinityImmuno）是一家位于加拿大的生物技术公司，一直专注于为生物药物研究提供高质量的试剂和服务。该公司以其专业的技术背景和丰富的产品线，在生物仿制药和单抗药研究领域赢得了广泛的认可，广泛应用于学术研究、生物技术和制药公司的研究工作。


AffinityImmuno产品包括：

（1）ELISA试剂盒：

AffinityImmuno生产的ELISA试剂盒具有高灵敏度、特异性和可重复性，用于测定临床前和临床血清血浆样本中的抗体药浓度，以及进行免疫学相关检测。这些试剂盒可用于检测多种疾病，如癌症、自身免疫病和感染病等。

（2）抗体：

公司提供多种抗体产品，包括针对癌症、自身免疫和内分泌疾病的新型靶点的抗体，以及用于细胞去除、阻断和激活研究的单克隆抗体。AffinityImmuno还可根据客户要求进行定制化开发，如多克隆抗体的制备。

（3）研发支持服务：

除了产品销售外，AffinityImmuno还提供高质量的研发支持服务，包括抗体发现、蛋白质工程和检测开发等。这些服务旨在帮助客户加速生物药物的研发进程，提高研发效率和质量。

<<< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Affinity Immuno品牌"> 艾美捷科技代理Affinity Immuno品牌
...
阅读详情
Protide-logo-1-600x314.png

<

艾美捷科技代理Protide Pharmaceuticals品牌全系列产品

Protide Pharmaceuticals, Inc.是一家专注于生物制药生产上游工艺的创新型公司。Protide Pharmaceuticals公司的核心产品为血清替代物，其核心价值在于提供高性能、化学成分明确、无动物来源的血清替代物和定制化培养基解决方案，帮助客户大幅减少生物制品生产过程中对胎牛血清或其他动物血清的依赖。，从而提高生物制品生产的效率、一致性、安全性和合规性。

除了血清替代物，Protide Pharmaceuticals公司也提供完整的、优化的无血清培养基配方，专门设计用于支持各种哺乳动物细胞系（如CHO, HEK293, Vero, MRC-5等）在生物反应器中进行高密度培养和高产率生产目标生物分子（如抗体、病毒载体、重组蛋白）。其产品应用于再生医学、肿瘤生物学、细胞生物能量学、肿瘤免疫学、转化医学、表观遗传学，胰岛细胞移植等领域。


ProtidePharmaceuticals页面.png

<

▎Protide Pharmaceuticals产品线

● 血清替代品/生物制品生产培养基

Protide Pharmaceuticals的血清替代品通过提供优质、生物一致且功能性的环境，显著改善细胞的生理状态。所有血清替代品均配制成 50 倍浓缩液，这大大降低了成本，并改善了储存和供应链活动。Protide血清替代品不含：酚红、生长因子、类固醇激素、糖皮质激素、细胞粘附分子、生长因子、类固醇激素等物质，可以在其缺失或存在的情况下进行有效研究。细胞分泌的蛋白质可以在不受污染性血清成分干扰的情况下实现高度纯化。


品名货号-规格产品描述
TCH™3001-40ml；3002-100ml；3005-100ml本血清替代品主要用于人类细胞培养及细胞分泌蛋白的生产。TCH™ 在培养其他哺乳动物细胞时同样有效，且不含动物蛋白。其成分仅包含经热处理的人源蛋白（即人血清白蛋白、人转铁蛋白、重组人胰岛素）。
VaxMax™6004-100ml；6005-500ml；6006-1L100倍浓缩液是一种高性价比产品，可显著降低总体血清需求量。在MDBK、MDCK、Vero、CRFK及猪睾丸细胞培养中，使用VaxMax™已展现出显著的产量提升。兽用疫苗生产商已采用VaxMax™来增强生产，同时降低总体成本。VaxMax™通常与0.5%至1% 的血清配合使用。
HemaPro™3300-40ml；3303-100ml本产品为无血清添加剂，专为人祖细胞培养而设计。可有效用于癌症干细胞、诱导多能干细胞和间充质干细胞 的研究。不含：促红细胞生成素；重组生长因子。
TM-235™2001-40ml；2002-100ml；2005-500ml本血清替代品具有与TCM™类似的特性，但额外添加了适用于需要更高血清浓度（通常超过10%）的细胞类型的成分。TM-235™是一种成分明确且多用途的替代品。
TCM™1001-40ml；1002-100ml；1005-500ml本产品是一种通用型血清替代品，适用于多种物种来源的广泛细胞类型。TCM™是一种成分明确且多用途的血清替代品，可有效用于研究生长因子的影响以及蛋白质的生产。


● 低温保护剂


品名货号-规格产品描述
Stemsol™ USP (DMSO)PP1250-5ml；PP1300-10ml；PP1350-50ml；PP1400-100ml本产品为干细胞冻存溶液，适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。
pZerve™5700-60ml;5720-20mlpZerve™ 是一款独特的冻存溶液，不含 DMSO、胎牛血清或动物蛋白。本品为即用型，无需任何稀释或进一步处理。适用细胞类型包括：肥大细胞、树突细胞、间充质细胞、人转移性前列腺腺癌细胞、人结肠腺癌细胞，人转化胚肾细胞。
Cellvation™5001-60mlCellvation™ 是一款独特的冻存溶液，不含 DMSO 或胎牛血清。本品使用便捷，并能提供最佳的细胞复苏效果。在冷冻程序启动前，细胞可置于 Cellvation™ 中较长时间。本品为即用型，适用于无血清培养基或含血清培养基培养的细胞。
MiCord™ 55% DMSO USP 5% Dextran USP1505-5ml;1500-7ml;;1700-10ml;1550-50ml;1600-100ml本产品为干细胞冻存溶液，适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。
2-8CELLsius™ + DMSO，5% DMSOPP338DM5-10ml;PP338DM5-100ml;PP338DM5-100B当与DMSO配合使用时，2-8CELLsius™可用作冻存液。2-8CELLsius™ + DMSO冻存液是一种细胞保护性、无蛋白溶液，含有生物稳定剂，可支持冻融后细胞的高存活率。其通过针对超低温下细胞生理学的创新方法，实现最佳的细胞复苏效果。不含：任何生长因子，激素以及抗生素。
2-8CELLsius™ + DMSO，10% DMSOPP338DM10-10ml;PP338DM10-100ml；PP338DM10-100B；PP338DM10-1000B
2-8CELLsius™ + DMSO，20% DMSOPP338DM20-100B；PP338DM20-1000B


● 细胞处理


品名货号-规格产品描述
2-8CELLsius™PP338-100ml；PP338-500ml；PP338-1000；PP338-1000B即用型、平衡、细胞保护性、无蛋白溶液，含生物稳定剂，适用于：短期储存、再生医学、干细胞处理以及生物材料运输。
Dextran 40 in 0.9% NaClPP1850-50ml;PP1840-1000ml;PP1880-250ml;PP1900-500ml-
Dulbecco’s Phosphate Buffered Saline (10X) PBSPBS210-500ml;PBS211-1000ml无钙镁储存条件：15-30°C；包装于PETG瓶；稳定性：至少6个月；无菌过滤
Dulbecco’s Phosphate Buffered Saline (1X) PBSPBS200-500ml;PBS201-1000ml无钙镁储存条件：15-30°C；包装于PETG瓶；稳定性：至少6个月；无菌过滤
Hank’s Balanced Salt Solution (1X) HBSSHS240-500ml;HS241-1000ml无钙镁配方：储存温度 4-8°C；无酚红配方；稳定性：至少6个月；含0.35克/升 碳酸氢钠；含1000毫克/升 D-葡萄糖；包装于 PETG 瓶，无菌过滤。cGMP 规范生产。


● CIT 胰岛细胞溶液


品名货号-规格
Cold Storage/Purification Stock Solution111098-1L
Phase I Solution060899-1L


" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Protide Pharmaceuticals品牌全系列产品"> 艾美捷科技代理Protide Pharmaceuticals品牌全系列产品
...
阅读详情
MYOCEA LOGO 2.5比1.jpg

艾美捷科技代理代理MYOCEA品牌产品。


MYOCEA是一家专注于肌肉生物学和细胞培养技术的公司，致力于为科研和工业应用提供创新的肌肉细胞模型和相关产品。MYOCEA 以其独特的MyoCells™技术平台而闻名，该平台能够生成高度功能化的肌肉细胞，广泛应用于药物开发、毒理学测试、食品科学和再生医学等领域。MyoCells™技术平台能够生成与体内肌肉细胞高度相似的体外模型，为研究肌肉生物学和相关疾病提供了强大的工具。MYOCEA主要产品和技术包括：

（1）MyoCells™ 平台

MyoCells™ 肌肉细胞，高度功能化的肌肉细胞，具有与体内肌肉相似的生理特性。

MyoCells™ 培养基，专为肌肉细胞优化，支持细胞生长和功能维持。

MyoCells™ 试剂盒，包含细胞、培养基和实验指南，方便用户快速开展实验。


（2）药物开发工具

肌肉毒性测试，用于评估药物对肌肉细胞的毒性。

肌肉功能分析，提供高灵敏度的收缩性和代谢活性检测工具。

个性化药物筛选，基于患者来源的肌肉细胞模型，支持个性化医疗研究。


（3）食品科学应用

细胞培养肉研究，提供高质量的肌肉细胞，用于细胞培养肉开发。

食品添加剂测试，用于评估食品添加剂对肌肉细胞的影响。


（4）再生医学工具

肌肉再生研究，提供肌肉细胞模型，用于研究肌肉再生和修复机制。

组织工程，支持肌肉组织工程和生物材料开发。


（5）定制服务

定制肌肉细胞模型，根据客户需求开发特定的肌肉细胞模型。

合同研究服务（CRO），提供从实验设计到数据分析的全流程服务。


<< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MYOCEA品牌产品"> 艾美捷科技代理MYOCEA品牌产品
...
阅读详情
591592593594595596597598599600

Copyright © 2026 Powered by PANAGENE中国区代理商/公司/官网   sitemap